Clinical Trial Update: The Drug -Drug Interaction of SP2086 and Glyburide [Phase 1]

View source ↗

Summary

Phase 1 trial investigating the drug-drug interaction between SP2086 and glyburide has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Glyburide (glyburide)
• SP2086

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Type 2 Diabetes | Phase 1 | Status: COMPLETED